surpass trial tirzepatide clinical enrollment A Phase 1 Multiple Dose Study of in Chinese Patients with Type 2 Diabetes SURPASS-5: Tirzepatide lowers HbA1c in
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
























